Scarica l'app Stockscreener
10.46
2.14%
-0.28
Precedente Chiudi:
$10.74
Aprire:
$10.63
Volume 24 ore:
92,520
Relative Volume:
0.08
Capitalizzazione di mercato:
$673.52M
Reddito:
$65,400
Utile/perdita netta:
$-46.34M
Rapporto P/E:
-12.16
EPS:
-0.86
Flusso di cassa netto:
$-38.74M
1 W Prestazione:
-4.45%
1M Prestazione:
-6.16%
6M Prestazione:
+106.89%
1 anno Prestazione:
+190.33%
Intervallo 1D:
$10.43
$10.80
Intervallo di 1 settimana:
$10.16
$11.41
Portata 52W:
$2.89
$13.85
CorMedix Inc Stock (CRMD) Company Profile
Nome
CorMedix Inc
Settore
Industria
Telefono
908-517-9500
Indirizzo
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Confronta CRMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| CRMD | 10.47 | 673.52M | 65,400 | -46.34M | -38.74M | -0.86 |
| VRTX | 445.46 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 736.00 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 585.04 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.45 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.20 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-02-17 | Iniziato | Needham | Buy |
| 2020-09-29 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-09-21 | Iniziato | Truist | Buy |
| 2019-12-18 | Iniziato | B. Riley FBR | Buy |
| 2019-03-26 | Reiterato | H.C. Wainwright | Buy |
| 2018-12-06 | Iniziato | ROTH Capital | Buy |
| 2017-09-25 | Reiterato | H.C. Wainwright | Buy |
| 2017-08-10 | Reiterato | Rodman & Renshaw | Buy |
| 2017-05-05 | Reiterato | Rodman & Renshaw | Buy |
| 2016-11-11 | Reiterato | FBR & Co. | Outperform |
| 2016-03-17 | Reiterato | FBR Capital | Outperform |
| 2016-03-03 | Iniziato | FBR Capital | Outperform |
| 2015-11-16 | Reiterato | ROTH Capital | Neutral |
| 2015-10-29 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Downgrade | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Reiterato | ROTH Capital | Buy |
| 2011-10-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
CorMedix Inc Borsa (CRMD) Ultime notizie
Cormedix EVP Elizabeth Hurlburt sells $1.57m in stock - Investing.com
When the Price of (CRMD) Talks, People Listen - Stock Traders Daily
Nomura Holdings Inc's Strategic Reduction in CorMedix Inc Shares - GuruFocus.com
Here's Why CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Is The Least Of Shareholders' Concerns - Simply Wall St
CorMedix (CRMD) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN
Best Momentum Stocks To Buy For November 8th - Barchart
Best Momentum Stocks to Buy for November 8th - Yahoo Finance
Trend Tracker for (CRMD) - Stock Traders Daily
CorMedix's SWOT analysis: defencath launch boosts stock outlook By Investing.com - Investing.com Australia
CorMedix's SWOT analysis: defencath launch boosts stock outlook - Investing.com India
Wall Street Analysts See a 52.15% Upside in CorMedix (CRMD): Can the Stock Really Move This High? - Yahoo Finance
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium - The Manila Times
Analysts Just Made A Massive Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts - Simply Wall St
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic - Yahoo Finance UK
CorMedix: Q3 Earnings Snapshot - AOL
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate - Yahoo Finance
Recent 23% pullback isn't enough to hurt long-term CorMedix (NASDAQ:CRMD) shareholders, they're still up 188% over 1 year - Simply Wall St
CorMedix Inc. (NASDAQ:CRMD) Q3 2024 Earnings Call Transcript - Insider Monkey
CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates - MSN
CorMedix Inc. Reports Q3 2024 Financial Results - TipRanks
CorMedix (CRMD) Q3 2024 Earnings Call Transcript - The Motley Fool
Earnings call: CorMedix Inc. reports Q3 financials, DefenCath drives growth By Investing.com - Investing.com South Africa
Earnings call: CorMedix Inc. reports Q3 financials, DefenCath drives growth - Investing.com
CorMedix Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update - The Manila Times
CorMedix earnings beat by $0.06, revenue topped estimates - Investing.com UK
Stellantis N.V. (STLA-N) QuotePress Release - The Globe and Mail
Cormedix Inc (CRMD) Q3 2024 Earnings Report Preview: What To Loo - GuruFocus.com
CorMedix stock soars to 52-week high, hits $13.52 - Investing.com India
CorMedix 2.0: New Leadership, New Approval, New Focus (NASDAQ:CRMD) - Seeking Alpha
CorMedix stock soars to 52-week high, hits $13.52 By Investing.com - Investing.com UK
(CRMD) Trading Advice - Stock Traders Daily
Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital + - Seeking Alpha
Spotify Technology S.A. (SPOT-N) QuotePress Release - The Globe and Mail
CorMedix Inc. Announces New Data at ASN Kidney Week 2024 - The Manila Times
Wall Street Analysts Believe CorMedix (CRMD) Could Rally 142.25%: Here's is How to Trade - MSN
Mauritian Rupee/U.S. Dollar (MURUSD) QuotePress Release - The Globe and Mail
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024 - The Manila Times
CorMedix Inc. (CRMD): A Bull Case Theory - Insider Monkey
CorMedix stock soars to 52-week high, hits $11.07 By Investing.com - Investing.com Australia
CorMedix Inc Azioni (CRMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):